Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Rapamycin With Grapefruit Juice for Advanced Malignancies
| Conditions: | Tumors|Neoplasm Metastasis |
| Start Date: | September 1, 2006 |
| Phase: | Phase I |
| Status: | Active, not recruiting |
| NCT ID: | NCT00375245 |
| Study Type: | Interventional |
| Intervention: | Drug: Rapamycin (sirolimus)|Other: Grapefruit Juice |
| Study Design: | Allocation: Non-Randomized|Control: Uncontrolled|Endpoint Classification: Safety Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | University of Chicago |
| Ages: | Adult|Senior |
| Enrollment: | 64 |
| Funded By: | Other |
| First Received: | September 11, 2006 |
| End Date: | November 1, 2009 |
| Last Updated: | February 12, 2009 |
| Last Verified: | February 1, 2009 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
